EST Cathie Wood’s ARK Investment bought 147K shares of Crispr Therapeutics (CRSP) todayStay Ahead of the Market:Discover outperforming ...

The stock market chugged along this week after Wall Street finally got good news on inflation. The Dow is up 382 points, or 0 ...

A look at Intellia Therapeutics, Inc. and Editas Medicine, Inc., including their restructuring and pipeline prioritization.

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

Shares of CRISPR Therapeutics CRSP have lost more than 30% in the past year. Though the stock soared at the onset of 2024, ...

With that in mind, let's consider two stocks that haven't performed well recently and are now near their 52-week lows but ...

Vertex Pharmaceuticals ( VRTX 3.06%) might be one of those special cases. Should you buy Vertex stock hand over fist before ...

CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

The most recent trading session ended with CRISPR Therapeutics AG (CRSP) standing at $38.36, reflecting a -1.26% shift from the previouse trading day's closing. The stock trailed the S&P 500, which ...

Dennison also describes how CRISPR screening tools will be key to further ... I think the reason is that the clinical team is relatively small, so they can buy into the project. We've got good links ...

Analysts with Needham say Instacart stock is a buy, as the firm is growing despite competition from Uber, Amazon and others.